CEO Roundtable: COVID a mixed bag on research output
COVID-19 has prompted a salvo of faster research and growth for some companies in Northern Colorado’s Life Sciences industry and has caused major lags for others.
That discussion was part of BizWest’s CEO Roundtable among a group of leaders of life-science companies and accelerators via video chat Tuesday morning.
COVID speeds or slows research and approvals
Rajan Bawa, the CEO of Fort Collins-based contract clinical study group CARE Research LLC, said his staff has had to come into the lab throughout the pandemic because it can’t take home the equipment needed to do research. The lab follows additional protocols to reduce the potential…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
Enliven Therapeutics finished the third quarter with $292 million in cash, which, the company said,…
-
Biodesix Inc. (Nasdaq: BDSX), a life-sciences company that specializes in developing tools to detect lung…
-
Edgewise Therapeutics Inc., a Boulder-based muscle disease biopharmaceutical company, increased its research and development spending…
-
Arca Biopharma has completed its merger with Oruka Therapeutics Inc.
